← Evidence map

ArticleClinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology2026

MG-K10 in Moderate-to-Severe Asthma: Extending the Dosing Interval Without Compromising Efficacy.

Feizhou Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 42334095